CFR Presents

Asia Unbound

CFR experts give their take on the cutting-edge issues emerging in Asia today.

Posts by Author

Showing posts for "Yanzhong Huang"

Taiwan’s WHA Status in Limbo

by Yanzhong Huang
Taiwan Health Minister Yeh Ching-chuan reacts at this arrival at the 62nd World Health Assembly takes place at the United Nations European headquarters in Geneva May 18, 2009. The World Health Assembly is the annual meeting of the World Health Organization's (WHO) 193 Member States and it is the supreme decision-making body of WHO, It sets the policy for the Organization and approves its budget. (Denis Balibouse/Reuters) Taiwan Health Minister Yeh Ching-chuan reacts at this arrival at the 62nd World Health Assembly takes place at the United Nations European headquarters in Geneva May 18, 2009. The World Health Assembly is the annual meeting of the World Health Organization's (WHO) 193 Member States and it is the supreme decision-making body of WHO, It sets the policy for the Organization and approves its budget. (Denis Balibouse/Reuters)

The World Health Assembly (WHA), the executive body of the World Health Organization (WHO), will convene on May 23-28 in Geneva. While member states have received invitations to participate in this year’s WHA, the only assurance Taiwan has received from the WHO Secretariat is that “internal operations were ongoing.” Read more »

Pharmaceutical PPPs and China’s Contribution to Global Health Security

by Yanzhong Huang
Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015. China may more actively participate in global health innovation if it takes up more pharmaceutical public-private partnerships. Picture taken November 27, 2015. (Aly Song/Reuters) Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015. China may more actively participate in global health innovation if it takes up more pharmaceutical public-private partnerships. Picture taken November 27, 2015. (Aly Song/Reuters)

One of the major challenges in developing new medical countermeasures against threats to global health security—be it a new flu pandemic or rapid spread of a neglected disease—is the lack of an underlying commercial market to support the financial investment needed for expeditious drug development and scale-up. This challenge was demonstrated at the outset of the 2014 Ebola outbreak: even though the lethal virus was known for nearly forty years, there was no cure or vaccine on the market. Paradoxically, while political attention to global health issues has revved up since the Ebola outbreak, funding is as short as ever when it comes to research and development (R&D) to address novel or neglected diseases. The funding shortage could be exacerbated by competing global challenges such as the need to raise money for funding the initiatives of the COP21 and implementation of the UN Sustainable Development Goals. Read more »

Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example

by Yanzhong Huang
A worker makes his way on a bridge at Swiss pharmaceutical company Roche plant. Roche is the manufacturer of Avastin, a cancer medication used for off-label treatment for macular disease in place of the more expensive Lucentis. (Christian Hartmann/Reuters) A worker makes his way on a bridge at Swiss pharmaceutical company Roche plant. Roche is the manufacturer of Avastin, a cancer medication used for off-label treatment for macular disease in place of the more expensive Lucentis. (Christian Hartmann/Reuters)

Several years ago an Indonesian girl named Widya posted a message on my blog. She asked where she could obtain the drug Sorafenib for her father, who was terminally ill with liver cancer. Her family had already spent a significant sum on her father’s healthcare and could not afford further treatment. I forwarded the message to a pharmaceutical executive in Jakarta, who responded that Sorafenib was available in Indonesia but a month’s dosage would cost around $4,500 (the average monthly salary in Jakarta is about $1,180). “I hope the patient has health insurance coverage, otherwise the family will have to pay out of pocket,” he said.

Read more »

Tu Youyou: An Outlier of China’s Scientific and Technological System

by Yanzhong Huang
Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr) Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr)

On October 5, a native Chinese scientist, Tu Youyou, won the Nobel Prize in medicine for her role in developing an antimalarial drug that saves millions of lives in Africa and Asia. The award is considered a milestone in China’s history of science and technology as Tu is not only the first Chinese citizen but also the first Chinese-trained scientist ever to be awarded the most prestigious award in science. In fact, unlike other Chinese Nobel laureates in science, all of whom had overseas training, Tu had neither study nor research experience abroad. The most important research that led to the discovery of the medicine for which she was awarded the prize, artemisinin, was conducted in China. Surprised but exalted, many Chinese have attributed this prize to China’s scientific and technological (S&T) regime. Already, social media in China is flooded with discussions on who will be the next Chinese scientist to win the prize. Read more »

China’s Think-Tank Great Leap Forward

by Yanzhong Huang
Released balloons are pictured near a Chinese flag during a military parade marking the 70th anniversary of the end of World War Two, at Tiananmen Square in Beijing, China, September 3, 2015. (Rolex Dela Pena/Reuters) Released balloons are pictured near a Chinese flag during a military parade marking the 70th anniversary of the end of World War Two, at Tiananmen Square in Beijing, China, September 3, 2015. (Rolex Dela Pena/Reuters)

China is experiencing a think-tank great leap forward. Governments, universities, and non-governmental actors have all jumped on the bandwagon of growing and creating think tanks. In responding to the government’s call to build fifty to a hundred high-end think tanks “with Chinese characteristics,” existing think tanks were quick to release reform and rebuilding plans, while new think tanks mushroomed in China. Just this month, at least ten new think tanks were reported to have been launched. In addition to those housed by universities, many are affiliated with government agencies (e.g., China National Tourism Administration) or media groups (e.g., Phoenix media group). As Professor Yan Xuetong of Tsinghua University observed, nowadays “each unit is building a think tank, and all universities are building think tanks.” It was reported that even some academic institutions focusing on studying history and archaeology have sought to transform themselves into think tanks. Read more »

The Rising Anti-Intellectualism in China: Part II

by Yanzhong Huang
Graduates dressed up as red guards, wait for their picture to be taken, in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song) Graduates dressed up as red guards, wait for their picture to be taken, in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song)

In my last blog post, I examined the rise of anti-intellectualism in China from a historical perspective. As if to corroborate my argument, last week police in China’s Jiangxi province detained Wang Lin, a semi-illiterate qigong (a Chinese spiritual martial art) mystic, for his role in the alleged kidnapping and murder of one of his former “disciples.” What dragged Wang into the limelight was not the incident itself, but the laundry list of his followers and clients exposed after Wang’s fall. They included Jack Ma, Jet Li, and a number of other celebrities and high-profile businessmen. Chinese websites also circulated photos showing Wang with high-ranking government officials, including several former Politburo Standing Committee members and at least four former central government ministers. Among them was the now disgraced railway minister Liu Zhijun, to whom Wang promised to set up a magic stone in his office so that he would never fall from power. Read more »

The Rising Anti-Intellectualism in China: Part I

by Yanzhong Huang
Graduates, in academic dress, pose for pictures in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song) Graduates, in academic dress, pose for pictures in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song)

On June 10, a blogger named Zhou Xiaoping was elected to head the newly established China Online Writers Association in Sichuan Province. He thus followed the career path of another popular blogger, Hua Qianfang, who was elected the Vice Chairman of the Writers Association of Fushun City in Liaoning Province in November 2014, an honor that is usually reserved for professional writers whose achievements in literature are well recognized. While both of them received only secondary school education, Zhou and Hua were invited to join the seventy most famous writers and artists in attending a symposium on art and literature in Beijing last year.  Read more »

Does MERS Pose a Serious Threat to China?

by Yanzhong Huang
A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu) A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu)

Last Friday, China confirmed its first case of Middle East Respiratory Syndrome (MERS) in Guangdong province. The now-confirmed South Korean MERS patient, who ignored travel warnings and lied about his conditions when flying to China, had been in close contact with seventy-seven people in the province. As of June 1, sixty-four have been quarantined while the thirteen others remain to be found. Read more »

Podcast: China’s Environmental Health Crisis – Challenges and Politics

by Yanzhong Huang
Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters) Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters)

After more than three decades of rapid industrialization and modernization, China is on the cusp of potentially becoming the world’s largest economy. Yet China’s economic miracle has imposed tremendous costs on the environment and public health. Topping this list is extensive air pollution, water pollution, and soil contamination—outdoor air pollution, for example, has been linked to 1.2 million premature deaths in China. The result, as shown in the recent viral documentary “Under the Dome,” has been an environmental health crisis that has profound economic, social, and political ramifications. The ascending popularity of the documentary, followed by its quick disappearance from all major websites in China, beget a series of questions on China’s environmental health crisis: What is the nature and magnitude of the crisis? What are its causes and consequences?  What is the response of the Chinese government to the crisis and is this response sufficient to the challenges at hand? Read more »

The Anti-Corruption Drive and Risk of Policy Paralysis in China

by Yanzhong Huang
China's Politburo Standing Committee members (2nd row from bottom, L to R) Wang Qishan, Zhang Dejiang, President Xi Jinping, Premier Li Keqiang, Liu Yunshan and Yu Zhengsheng (bottom row, 2nd R) sing Chinese national anthem at the closing session of the Chinese People's Political Consultative Conference (CPPCC) at the Great Hall of the People in Beijing, March 13, 2015. (Kim Kyung-Hoon/Courtesy: Reuters) China's Politburo Standing Committee members (2nd row from bottom, L to R) Wang Qishan, Zhang Dejiang, President Xi Jinping, Premier Li Keqiang, Liu Yunshan and Yu Zhengsheng (bottom row, 2nd R) sing Chinese national anthem at the closing session of the Chinese People's Political Consultative Conference (CPPCC) at the Great Hall of the People in Beijing, March 13, 2015. (Kim Kyung-Hoon/Courtesy: Reuters)

Like it or not, President Xi Jinping’s anti-corruption campaign is extremely popular among Chinese people. According to an online survey, “combating corruption” trails “income distribution” as the top two concerns of the Chinese public. There are already reports suggesting that the campaign has helped reduce the transaction cost for ordinary people to get things done in China. Read more »